↓ Skip to main content

Novel Therapeutic Targets in Depression and Anxiety: Antioxidants as a Candidate Treatment

Overview of attention for article published in Current Neuropharmacology, March 2014
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#12 of 673)
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
8 news outlets
blogs
3 blogs
twitter
2 tweeters
patent
3 patents
facebook
1 Facebook page
wikipedia
1 Wikipedia page

Citations

dimensions_citation
60 Dimensions

Readers on

mendeley
119 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Novel Therapeutic Targets in Depression and Anxiety: Antioxidants as a Candidate Treatment
Published in
Current Neuropharmacology, March 2014
DOI 10.2174/1570159x11666131120231448
Pubmed ID
Authors

Ying Xu, Chuang Wang, Jonathan Klabnik, James O' Donnell

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 119 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
United States 1 <1%
Poland 1 <1%
Unknown 116 97%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 28 24%
Student > Master 18 15%
Student > Ph. D. Student 17 14%
Researcher 14 12%
Student > Doctoral Student 12 10%
Other 22 18%
Unknown 8 7%
Readers by discipline Count As %
Agricultural and Biological Sciences 19 16%
Medicine and Dentistry 18 15%
Psychology 13 11%
Pharmacology, Toxicology and Pharmaceutical Science 13 11%
Biochemistry, Genetics and Molecular Biology 10 8%
Other 29 24%
Unknown 17 14%

Attention Score in Context

This research output has an Altmetric Attention Score of 90. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 February 2021.
All research outputs
#283,457
of 17,719,454 outputs
Outputs from Current Neuropharmacology
#12
of 673 outputs
Outputs of similar age
#7,335
of 272,384 outputs
Outputs of similar age from Current Neuropharmacology
#1
of 16 outputs
Altmetric has tracked 17,719,454 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 673 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.3. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 272,384 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.